Role of latent tuberculosis infections in reduced COVID-19 mortality: Evidence from an instrumental variable method analysis.
Ontology highlight
ABSTRACT: Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, there has been significant interest in the potential protective effect of the Bacillus Calmette-Guerin (BCG) vaccine against COVID-19 mortality. This effect has been attributed to innate immune responses induced by BCG vaccination. However, these studies ignore an important fact: according to World Health Organization estimates, about a quarter of the world's population may have latent tuberculosis infection (LTBI), a condition in which there is no evidence of clinically active tuberculosis but persistent immune responses are stimulated by Mycobacterium tuberculosis antigens. Thus, both LTBI and BCG induce lifelong immunity and may provide immunological protection against COVID-19. In this study, the relationship betwe
SUBMITTER: Takahashi H
PROVIDER: S-EPMC7448767 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA